Show simple item record

dc.contributor.authorGaulton, A
dc.contributor.authorBellis, LJ
dc.contributor.authorBento, AP
dc.contributor.authorChambers, J
dc.contributor.authorDavies, M
dc.contributor.authorHersey, A
dc.contributor.authorLight, Y
dc.contributor.authorMcGlinchey, S
dc.contributor.authorMichalovich, D
dc.contributor.authorAl-Lazikani, B
dc.contributor.authorOverington, JP
dc.date.accessioned2018-06-28T14:47:47Z
dc.date.issued2012-01-01
dc.identifier.citationNucleic acids research, 2012, 40 (Database issue), pp. D1100 - D1107
dc.identifier.issn0305-1048
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/1968
dc.identifier.eissn1362-4962
dc.identifier.doi10.1093/nar/gkr777
dc.description.abstractChEMBL is an Open Data database containing binding, functional and ADMET information for a large number of drug-like bioactive compounds. These data are manually abstracted from the primary published literature on a regular basis, then further curated and standardized to maximize their quality and utility across a wide range of chemical biology and drug-discovery research problems. Currently, the database contains 5.4 million bioactivity measurements for more than 1 million compounds and 5200 protein targets. Access is available through a web-based interface, data downloads and web services at: https://www.ebi.ac.uk/chembldb.
dc.formatPrint-Electronic
dc.format.extentD1100 - D1107
dc.languageeng
dc.language.isoeng
dc.publisherOXFORD UNIV PRESS
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectHumans
dc.subjectProteins
dc.subjectPharmaceutical Preparations
dc.subjectUser-Computer Interface
dc.subjectDatabases, Factual
dc.subjectDatabases, Protein
dc.subjectDrug Discovery
dc.titleChEMBL: a large-scale bioactivity database for drug discovery.
dc.typeJournal Article
rioxxterms.versionofrecord10.1093/nar/gkr777
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by-nc/4.0
rioxxterms.licenseref.startdate2012-01
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfNucleic acids research
pubs.issueDatabase issue
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Computational Biology and Chemogenomics
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Computational Biology and Chemogenomics
pubs.publication-statusPublished
pubs.volume40
pubs.embargo.termsNot known
icr.researchteamComputational Biology and Chemogenomics
dc.contributor.icrauthorAl-Lazikani, Bissan


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0